Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
Clinical trial NCT00330551 · COMPLETED
Trial details
- NCT number
- NCT00330551
- Sponsor
- University of California, Los Angeles
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2012-11-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.